which is translocated to one of the 14q+ chromosomes, is in its germ-line configuration more than 14 kilobases away from both the JH segment and the heavy chain enhancer that is located between the JH and ,u switch region. Based on these findings, we propose a model of some aspects of B-cell oncogenesis according to which B-cell neoplasms carrying translocations involving the heavy chain loci on both human chromosomes 14 are the result of a multiple step process.
Dalla-Favera et al. (1) have shown that the c-myc oncogene, which is located on band q24 of human chromosome 8 (1-3), translocates to the immunoglobulin heavy chain locus on the involved chromosome 14 in Burkitt lymphoma with the 8;14 translocation. In some cases, the translocated c-myc gene is in its germ-line configuration; in others, it is rearranged head-to-head with the involved heavy chain locus (1, 3!-5) . In Burkitt lymphoma with the variant 8;22 and 2;8 translocations, the c-myc gene remains in its germ-line configuration on the involved human chromosome 8 (8q+), whereas either the X or the K immunoglobulin light chain locus is translocated to the involved chromosome 8 (6) (7) (8) . The consequence of these different chromosome rearrangements is a deregulation of the involved c-myc gene so that it is transcribed constitutively at an elevated level (6, 7, 9) , while the uninvolved c-myc gene on chromosome 8 is either transcriptionally silent (6, 7, 9, 10) or expressed at very low levels (unpublished observations). Somatic cell hybrids between Burkitt lymphoma cells and fibroblasts do not transcribe the translocated c-myc oncogene but somatic cell hybrids between Burkitt lymphoma and plasmacytoma cells do, which suggests that elements within the three immunoglobulin loci are capable of activating transcription in cis over considerable distances (9) (10) (11) .
Recently, we have used recombinant DNA technology to investigate the chromosome rearrangements occuri-ng in Bcell lymphomas and leukemias of adults. Translocations of either the long arm of chromosome 11 (ql3-+qter) or the long arm of chromosome 18 (q21-*qter) to band q32 of chromosome 14 have been observed in diffuse large-cell lymphoma (12) , diffuse small-cell lymphoma (13, 14) , chronic lymphocytic leukemia of the B-cell type (15) , multiple myeloma (16) , and follicular lymphoma (13, 14) . Recently, we have cloned the chromosomal breakpoint of B-cell leukemias and lymphomas with the t(11;14)(q13;q32) translocation (12) and have shown that the breakpoints in three separate tumors with this translocation occurred within a 4-kilobase (kb) stretch of DNA (unpublished observations). We have inferred that at band q13 of human chromosome 11 is located a locus, which we named bcl-J, that is activated by its proximity to the heavy chain locus and is involved in the expression of neoplasia in B cells carrying the 11;14 translocation (17, 18) .
In this report, we have characterized a cell line, which we call 380 and which was derived from a patient with acute lymphoblastic leukemia, that carries both the 14;18 and the 8;14 translocations. This cell line has provided us the opportunity to clone DNA sequences from chromosome 18 flanking the breakpoint on chromosome 14 (19) and to speculate concerning the sequence of molecular events involved in the pathogenesis of this neoplasm.
MATERIALS AND METHODS
Case History. The 380 cell line was derived from the peripheral blood of a 15-year-old boy, who was first admitted to the hospital in April 1983 for pain in the upper left abdomen. Physical examination revealed only moderate spleen enlargement. Hematologic tests showed an increased leukocyte count (24,600 per mm3), a normal hemoglobin level, and normal erythrocyte and platelet counts. Morphologic examination of peripheral blood and bone marrow smears showed that >30% of nucleated cells were undifferentiated blasts with a high nucleoplasm/cytoplasm ratio, thin chromatin, and two or three nucleoli. On the basis of these observations and cytochemical and immunologic characteristics (summarized in Table 1 ), the boy was considered to have an acute lymphoblastic leukemia type L2 (FAB classification). $To whom reprint requests should be addressed.
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In September 1983, a relapse rapidly developed and the leukocyte count rose to 620,000 per mm3. Chemotherapy was ineffective, and the patient died in a few days.
Establishment of the Cell Line. Peripheral blood was obtained both during the first admission (prior to any therapy) and during the relapse. The blood was mixed 9:1 with 3.4 M sodium citrate, layered on Lymphoprep (specific density 1.070; Meyggard, Oslo, Norway), and centrifuged to remove erythrocytes and granulocytes (20) . Cells collected from the interface were washed, seeded at 1 x 108 per ml in RPMI 1640 medium with 15% fetal calf serum, and incubated at 370C in a 5% CO2 atmosphere. On both occasions, the cells maintained the ability to grow indefinitely in suspension culture and two cell lines were established. The cell line 380 was derived from the blood sample obtained during relapse.
Morphologic and Cytochemical Studies. Morphologic and cytochemical studies were done as described (21) .
Chromosome Analysis. The cells were incubated for 30 min with colchicine (0.05 ,tg/ml), harvested by centrifugation, suspended in 0.075 M KCI, and, after 20 min, fixed with methanol/acetic acid (3:1, vol/vol). The air-dried preparations were trypsin/Giemsa banded by standard methods (22) .
Assay for Epstein-Barr Virus Nuclear Antigen. Staining for this antigen was carried out as described (23) .
Surface Antigen Analysis. Murine monoclonal anti-human antibodies were used to detect surface-antigen determinants. The B33.1 antibody against an Ta (I-region associated)-like antigen was provided by G. Trinchieri, and the J5 antibody was obtained from J. Ritz (Boston) (24) . OKT3, OKT4, OKT6, OKT8, and OKT11 monoclonal antibodies were purchased from Ortho. An antibody specific for the transferrin receptor (L5.1) was prepared as described (25) . Goat antiserum to calf terminal deoxynucleotidyltransferase (TdT), cross-reactive with human TdT (26) Southern (30) . The c-myc probe (Ryc 7.4) was a c-myc cDNA containing sequences derived from the two coding exons of the c-myc oncogene (9) . The C,, probe was an EcoRI 1.2-kb fragment of the genomic ,u heavy chain constant region (C.) DNA (18) . The CK probe was a K cDNA clone in M13mp7 (7) . The CA probe was a genomic clone (Chr 22A 5) of the CA gene (6) However, strong positive reactions were observed with antibodies directed against Ia-like antigens (B33.1) and against CALLA, the common acute lymphocytic leukemia antigen (J5). The cells did not react with antibodies specific for Tcell markers (Table 1) .
Intracellular Markers. No expression of Epstein-Barr virus nuclear antigen (EBNA) was detected in the 380 cells. In addition, the cells were negative for the expression of cytoplasmic immunoglobulins, but were positive for TdT as determined by immunofluorescence (Table 1) . On the basis of the analysis of surface and intracellular markers, the phenotype of 380 cells is that of a pre B-cell leukemia (Table 1) .
Karyotypic Analysis. As illustrated in Fig. 1 , cells of the 380 line had two reciprocal translocations involving both human chromosomes 14. One of the 14q+ chromosomes was the result of translocation of the distal end of the long arm of chromosome 8 to the heavy chain locus on band q32 of chromosome 14, while the other 14q+ chromosome resulted from translocation of the segment q21-*qter of human chromosome 18 to the heavy chain locus. No other abnormality in chromosome morphology was detected. Immunoprecipitation of Radiolabeled Immunoglobulins.
Immunoprecipitation of labeled secreted and cytoplasmic proteins from 380 cells with antiserum against immunoglobulin did not result in the appearance of any specific immunoglobulin band upon NaDodSO4/PAGE (Fig. 2) . In contrast, we detected immunoglobulin chain synthesis in the two lymphoma cell lines BL2 and JD38, which carry the 8;22 and the 8;14 chromosome translocations, respectively.
Immunoglobulin Gene Rearrangements in the 380 Cells. To determine whether cells of the 380 line are in the B-cell lineage, 380-cell DNA was digested with BamHI, which cleaves outside the human C,. gene (22) . After agarose gel electrophoresis and Southern transfer, the DNA was hybridized with the C,. probe (22) . As shown in Fig. 3A , the 380 cells carry two rearranged C,, genes; one is found in an 18.5-kb fragment and the other in a 14-kb fragment. Hybridization with a probe specific for the joining (JH) segment (32) of the heavy chain locus labeled the same 18.5-and 14-kb bands (Fig. 3B) , indicating that the JH and C, segments are both present in each of the DNA fragments. This interpretation was confirmed by examining recombinant clones derived from joinings on the 14q+ chromosomes of the 380 cells (19) .
As shown in Fig. 4A , hybridization of a Southern blot with a probe specific for C,, did not result in the appearance of any band, indicating that both C, genes have been deleted in the 380 cells. In contrast, we detected two rearranged CA bands (5.8 and 2.6 kb) from these cells, which indicates rearrangements of CA genes on both chromosomes 22 (Fig. 4B) . The difference in the size of the upper CA band in the 380 cells and in human PAF fibroblasts, as shown in Fig. 4B , is due to genetic polymorphism (6). Since we detected rearrangements of both , heavy chain genes, deletion of both C,, genes, and rearrangements of both CA genes, we can conclude that the 380 cells belong to the Bcell lineage, even if they do not express any immunoglobulin chains (Fig. 2) . The results of the studies of surface markers (Table 1) are consistent with this interpretation. The lack of expression of immunoglobulin heavy chains by these cells may be explained by the fact that one of the translocations involved the productively rearranged Au gene.
In Burkitt lymphomas with the 8;14, 8;22, and 2;8 translocations (6, 7, 22, 32) and in B-cell leukemias and lymphomas with the 11;14 translocation (17, 18) , the productively rearranged immunoglobulin gene is on the uninvolved chromosome 14, 22, or 2, while the excluded immunoglobulin allele is on the chromosome involved in the translocation. It seems likely, therefore, that the first translocation that occurred in the evolution of the 380 tumor cells involved the unproductively rearranged ,t gene and that the second translocation involved the productively rearranged ,u gene, leading to its inactivation (Fig. 5) .
Involvement of the c-myc and bCl-2 Loci in the 380 Leukemia Cells. Southern blotting analysis of BamHI-digested DNA showed that the c-myc oncogene is in its germ-line configuration in the 380 cells (Fig. 6) and indicates that the translocated c-myc gene is >14 kb from the chromosomal breakpoint, since the BamHI site is located 14 kb 5' of the c-myc gene (6) . Recently, we cloned the sequences 5' of the JH region on the 18.5-kb BamHI C, fragment (Fig. 3) and found that these sequences derive from chromosome 8 (19) . We have also cloned the segment of chromosome 18 at the breakpoint on the 14q+ chromosome of the 14;18 transloca- tion (19) and have termed the locus defined by this DNA probe bcl-2 (B-cell leukemia/lymphoma 2). With this probe, we detected rearrangement and recombination of the bcl-2 locus with the C, locus in the 380 cells (19) (Fig. 7) . 
DISCUSSION
We have studied human leukemia cell line 380 that carries an 8;14 and a 14;18 translocation with breakpoints similar to those described in Burkitt lymphoma (1, 33) and follicular lymphoma (13, 14, 19) (1) .
A possible sequence of events in the development of a Bcell leukemia with two such chromosomal translocations follows. The 14;18 translocation may have occurred in an activated B cell and involved the excluded heavy chain allele on band q32 of chromosome 14 and the bcl-2 locus on chromosome 18 (Fig. 5) . This translocation placed the bcl-2 gene close to a heavy chain enhancer on the 14q+ chromosome leading to the activation and constitutive expression of this putative oncogene. This in turn resulted in clonal expansion of the B cells carrying the 14;18 translocation and in a relatively low-grade malignancy (Fig. 5) .
Within the neoplastic clone of proliferating B cells, the probability for additional random chromosome rearrangements was increased (34) . One of these additional changes, a translocation between chromosomes 8 and 14, might have occurred in a neoplastic B cell. This second translocation, which probably affected the productively rearranged , locus on the other chromosome 14, then resulted in the activation of the translocated c-myc oncogene, leading to a high-grade malignancy.
In this sequence, the 14;18 translocation is considered to be an early step in the pathogenesis of this leukemia. A similar role in expanding a B-cell pool susceptible to the effects of the 8;14 translocation might be assigned, in other circumstances, to continuous exposure to a strong immunogen such as malaria or to a virus, such as Epstein-Barr virus, that is capable of inducing B-cell proliferation.
The suggested role of the second translocation [t (8;14) ] in this leukemia is analogous to that of sequential karyotypic alterations in the biological progression of other types of neoplasia, such as chronic granolocytic leukemia, to a more aggressive phase (34) .
The rare lymphomas and leukemias that are found to have either both 14;18 and 8;14 translocations or both 11;14 and 8;14 translocations should allow a better understanding of the sequential steps and the multiple genes that may be in volved in the pathogenesis of many B-cell neoplasms in man.
Note Added in Proof. A case of acute leukemia with an 8;14 and a 14;18 translocation and with a phenotype similar to that of 380 cells has been reported (35) .
